At a glance
ClinicalIndex Comparison RecordN/ACompleted· 19 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-Phased, Multi-Center Study to Evaluate Safety and Device Performance of the Medtronic Hospital Glucose Management System (HGMS) in Critically Ill Adult Patients
In Brief
An observational study for Hyperglycemia. Completed, enrolled 19 participants across 1 site.
Detailed Summary
The purpose of this study is to assess safety and device performance of the Medtronic Hospital Glucose Management System (HGMS) for up to 72-hours.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHyperglycemia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2012
Primary CompletionAug 2012
Study CompletionSep 2012
First PostedJan 2013
TodayJul 2026
First PostedJan 9, 2013
Enrollment StartMar 1, 2012
Primary CompletionAug 1, 2012
Study CompletionSep 1, 2012
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 13.5 years ago